Press Releases
🌏 NMPA Page 5NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 49–60 of 97 articles
WuXi Biologics Chengdu Microbial Manufacturing Site Reaches Structural Completion, Targets 2026 GMP Production
Quasar Medical Opens New Thailand Manufacturing Facility to Expand MedTech Production Capacity
Daewoong Pharmaceutical NABOTA Master Class Highlights PrabotulinumtoxinA Safety for High-Dose Treatments
Amcor Opens $35M Healthcare Packaging Facility in Malaysia to Strengthen Southeast Asia Medical Supply Chain
Transcarent Partners with SmithRx to Expand Pharmacy Benefits Platform for Lower Drug Costs
HanchorBio Partners with Bloomberg to Enhance Drug Development Intelligence and Biopharma Strategy
CatalYm Doses First Patient in Phase 2/3 Trial of Visugromab for Cancer Cachexia
Spinogenix Launches Phase 2b/3 CLARITY Trial of SPG601 for Fragile X Syndrome Treatment
Samsung Bioepis Begins Phase 1 Trial for Novel ADC SBE303, Expands Sandoz Biosimilar Partnership
Fosun Health Wins Three Awards at GlobalHealth Asia-Pacific Forum 2026, Showcases China Solution Strategy
MorphoSys' MINJUVI (Tafasitamab) Approved in Australia for Relapsed/Refractory Follicular Lymphoma
Anixa Biosciences Lira-cel CAR-T Therapy Shows Positive Survival Data in Ovarian Cancer Phase 1 Trial